KCNN2 and movement disorder: All patients with pathogenic KCNN2 variants had motor and language developmental delay, intellectual disability often associated with early-onset movement disorders encompassing cerebellar ataxia, and/or extrapyramidal symptoms (NEDMAB OMIM 619725) [38].